23andMe, Inc. is a privately-held company dedicated to helping individuals understand their own genetic information using recent advances in DNA analysis technologies and web-based interactive tools. 23andMe enables individuals to gain deeper insights into personal ancestry, genealogy and inherited traits. 23andMe was founded in April 2006 by Linda Avey and Anne Wojcicki.

Financials

Date Type Amount Investors Valuation
05/01/07 Series A 9M Mohr Davidow Ventures, New Enterprise Associates, Draper Fisher Jurvetson, US Venture Partners Unknown
01/01/11 Series C 31M Unknown
12/01/12 Other 50M Unknown

People

Competitors

DNATraits: DNATraits specializes in DNA testing to identify genetic disorders and susceptibility to inherited diseases and characteristics.… See Company Profile »
Family Tree DNA: Founded in April 2000, Family Tree DNA was the first company to develop the commercial application… See Company Profile »
GenePartner: GenePartner is a provider of genetic research services based in Switzerland. GenePartner’s service has been designed… See Company Profile »
Pacific Biosciences: Pacific Biosciences (PacBio), headquartered in Menlo Park, CA, is a startup biotechnology company developing a transformative… See Company Profile »
Complete Genomics: Complete Genomics (CGI) is a high-performance DNA sequencing company whose mission is to dramatically reduce the… See Company Profile »

View more details about all 6 competitors

News

Pharma startup gets $30M for genetic cancer treatments

April 11, 2013 11:09 pm

This story is part of a series exploring the themes of our upcoming health tech conference, May 20-21 in San… Continue reading ⟩

Peter Thiel-backed MetaMed brings personalized health care — but only to the 1 percent

March 1, 2013 10:02 pm

Futurist and entrepreneur Michael Vassar has an issue with the U.S. medical system. He hopes to “humiliate” it into providing… Continue reading ⟩

Mark Zuckerberg, Sergey Brin, & Yuri Milner launch $33M ‘Breakthrough Prize’ in life sciences

February 20, 2013 5:09 pm

Step aside, Nobel. You’ve got some competition in the prize category. If you want to live longer, your chances may… Continue reading ⟩